Refuted
Individual vs. Structural
IndividualStructural

Relapse proves treatment failure and lack of willpower

Relapse proves treatment has failed and that the patient lacks the willpower to recover.

Addiction meets clinical criteria for a chronic relapsing brain disorder with neurobiological substrates; relapse rates are consistent with other chronic diseases and decline substantially with evidence-based treatment access, contradicting a moral weakness framing.

This claim analysis is fresh and accurate as of 2026-07-07

Who benefits from the prevailing framing
Private insurance companies that deny addiction treatment coverage, criminal justice systems that substitute incarceration for treatment, and pharmaceutical companies that profit from the absence of low-cost public treatment infrastructure.
Comparator cases
Portugal (decriminalization + treatment, 2001)Switzerland (heroin-assisted treatment program, 1994)Canada (supervised consumption sites + naloxone)Germany (substitution therapy as first-line treatment)